Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

ETV2 Antikörper (AA 1-335)

Der Kaninchen Polyklonal anti-ETV2 Antikörper (ABIN7869208) detektiert spezifisch ETV2 in WB, ELISA und FACS. Dieser Antikörper reagiert spezifisch mit Proben aus Maus und Ratte.
Produktnummer ABIN7869208
644,88 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 6 bis 9 Werktagen

Kurzübersicht für ETV2 Antikörper (AA 1-335) (ABIN7869208)

Target

Alle ETV2 Antikörper anzeigen
ETV2 (Ets Variant 2 (ETV2))

Reaktivität

  • 20
  • 4
  • 3
  • 2
  • 1
  • 1
Maus, Ratte

Wirt

  • 22
  • 1
  • 1
Kaninchen

Klonalität

  • 24
Polyklonal

Konjugat

  • 16
  • 2
  • 2
  • 2
  • 1
  • 1
Dieser ETV2 Antikörper ist unkonjugiert

Applikation

  • 19
  • 12
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA, Flow Cytometry (FACS)
  • Bindungsspezifität

    • 10
    • 6
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-335

    Verwendungszweck

    ETV2 Antibody / ETS variant transcription factor 2

    Aufreinigung

    Immunogen affinity purified

    Immunogen

    E.coli-derived mouse ETV2 recombinant protein (Position: M1-Q335) was used as the immunogen for the ETV2 antibody.

    Isotyp

    IgG
  • Applikationshinweise

    Optimal dilution of the ETV2 antibody should be determined by the researcher.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL

    Buffer

    Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    After reconstitution, the ETV2 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
  • Target

    ETV2 (Ets Variant 2 (ETV2))

    Andere Bezeichnung

    ETV2

    Hintergrund

    ETV2 antibody detects ETS variant transcription factor 2, a nuclear DNA-binding protein encoded by the ETV2 gene on chromosome 19p13.3. ETV2 belongs to the ETS family of transcription factors and is an essential regulator of vascular and hematopoietic development. It is highly expressed in endothelial progenitor cells, embryonic mesoderm, and early hematopoietic lineages, where it drives the transcription of genes required for blood vessel and blood cell formation. ETV2 functions as a master transcriptional activator that initiates endothelial lineage commitment during embryogenesis.

    ETV2 directly binds to ETS consensus sequences in the promoters of endothelial genes, activating transcription of critical targets such as VEGFR2 (KDR), TIE2, and CDH5 (VE-cadherin). This activity positions ETV2 at the top of the transcriptional hierarchy controlling vasculogenesis and angiogenesis. It cooperates with transcription factors such as GATA2 and FOXC2 to orchestrate endothelial differentiation and vascular remodeling. ETV2 also transiently regulates hematopoietic gene expression, linking early vascular and blood development.

    Structurally, ETV2 contains an ETS DNA-binding domain responsible for recognizing GGAA/T motifs in target promoters and a transactivation domain that recruits coactivators such as CBP/p300. These interactions enable the chromatin remodeling necessary for endothelial gene induction. ETV2 belongs to the ETS family of transcription factors, which share highly conserved DNA-binding domains that control diverse developmental and cellular processes.

    Functionally, ETV2 plays a crucial role in embryonic vasculogenesis, angiogenesis, and reprogramming of somatic cells toward endothelial fates. Forced expression of ETV2 in fibroblasts can induce endothelial gene expression, demonstrating its potency as a lineage reprogramming factor. ETV2 also participates in VEGF and MAPK signaling pathways, coordinating growth factor responses during vascular morphogenesis. Co-localization studies have shown ETV2 associating with GATA2 and TAL1 in the nucleus, forming transcriptional complexes essential for endothelial specification.

    Dysregulation of ETV2 expression disrupts vascular and hematopoietic development and has been implicated in congenital heart defects and embryonic lethality in knockout models. In adult tissues, ETV2 expression is normally repressed, but its reactivation can promote angiogenesis in ischemic and regenerative contexts. Pathway involvement includes VEGF signaling, Notch signaling, and angiogenic transcriptional networks that coordinate vessel growth and stabilization.

    Immunohistochemical staining using ETV2 antibody reveals strong nuclear localization in vascular endothelial cells and embryonic tissues. ETV2 antibody from NSJ Bioreagents is an excellent reagent for research in endothelial cell differentiation, vascular biology, and transcriptional regulation of angiogenesis.

    UniProt

    P41163
Sie sind hier:
Chat with us!